CREBRF and head and neck squamous cell carcinoma: To confirm the role of CREBRF and NR3C2 in HNSCC drug resistance, FaDu and CAL27 cell lines were treated with either CREBRF and NR3C2 siRNA alone or in combination, and the sensitivity of these cells to cisplatin and 5-FU was determined.